Applying Public Health Screening Criteria: How Does Universal Newborn Screening Compare to Universal Tumor Screening for Lynch Syndrome in Adults with Colorectal Cancer?
- 648 Downloads
Institutions have increasingly begun to adopt universal tumor screening (UTS) programs whereby tumors from all newly diagnosed patients with colorectal cancer (CRC) are screened to identify who should be offered germline testing for Lynch syndrome (the most common cause of hereditary CRC). Given limited information about the impact of universal screening programs to detect hereditary disease in adults, we apply criteria used to evaluate public health screening programs and compare and contrast UTS with universal newborn screening (NBS) for the purpose of examining ethical implications and anticipating potential outcomes of UTS. Both UTS and a core set of NBS conditions clearly meet most of the Wilson and Jungner screening criteria. However, many state NBS panels include additional conditions that do not meet several of these criteria, and there is currently insufficient data to confirm that UTS meets some of these criteria. Comparing UTS and NBS with regard to newer screening criteria raises additional issues that require attention for both UTS and NBS. Comparisons also highlight the importance of evaluating the implementation of genomic tests to ensure or improve their effectiveness at reducing morbidity and mortality while minimizing potential harms.
KeywordsPublic health genomics Lynch syndrome Newborn screening Screening criteria Tumor screening
Support for Deborah Cragun’s time was provided, in part, by a NCI R25T training grant awarded to Moffitt Cancer Center (5R25CA147832-04).
Conflict of Interest
Deborah Cragun, Rita DeBate, and Tuya Pal report no conflicts of interest.
Human Studies and Informed Consent
No human studies were carried out by the authors for this article.
No animal studies were carried out by the authors for this article.
- Barrow, E., Alduaij, W., Robinson, L., Shenton, A., Clancy, T., Lalloo, F., et al. (2008). Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clinical Genetics, 74(3), 233–242. doi: 10.1111/j.1399-0004.2008.01035.x.PubMedGoogle Scholar
- Beamer, L. C., Grant, M. L., Espenschied, C. R., Blazer, K. R., Hampel, H. L., Weitzel, J. N., & MacDonald, D. J. (2012). Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30(10), 1058–1063. doi: 10.1200/JCO.2011.38.4719.Google Scholar
- Bellcross, C. A., Bedrosian, S. R., Daniels, E., Duquette, D., Hampel, H., Jasperson, K., et al. (2011). Implementing screening for Lynch syndrome among patients with newly diagnosed with colorectal cancer: Summary of a public health/clinical collaborative meeting. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 12(4), 152–162. doi: 10.1097/GIM.0b013e31823375ea.Google Scholar
- Bonadona, V., Bonaïti, B., Olschwang, S., Grandjouan, S., Huiart, L., Longy, M., et al. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA, the Journal of the American Medical Association, 305(22), 2304–2310. doi: 10.1001/jama.2011.743.PubMedGoogle Scholar
- Cicek, M. S., Lindor, N. M., Gallinger, S., Bapat, B., Hopper, J. L., Jenkins, M. A., et al. (2011). Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the colon cancer family registry. The Journal of Molecular Diagnostics: JMD, 13(3), 271–281. doi: 10.1016/j.jmoldx.2010.12.004.PubMedGoogle Scholar
- Collins, V. R., Meiser, B., Ukoumunne, O. C., Gaff, C., St John, D. J., & Halliday, J. L. (2007). The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 9(5), 290–297. doi: 10.1097/GIM.0b013e31804b45db.Google Scholar
- Cragun, D., Debate, R. D., Vadaparampil, S. T., Baldwin, J., Hampel, H., & Pal, T. (2014). Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through. Genetics in Medicine. doi: 10.1038/gim.2014.31.PubMedPubMedCentralGoogle Scholar
- Feuchtbaum, L., Dowray, S., & Lorey, F. (2010). The context and approach for the California newborn screening short- and long-term follow-up data system: preliminary findings. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 12(12 Suppl), S242–250. doi: 10.1097/GIM.0b013e3181fe5d66.Google Scholar
- Frazier, D. M., Millington, D. S., McCandless, S. E., Koeberl, D. D., Weavil, S. D., Chaing, S. H., & Muenzer, J. (2006). The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005. Journal of Inherited Metabolic Disease, 29(1), 76–85. doi: 10.1007/s10545-006-0228-9.PubMedGoogle Scholar
- Haddow, J. E., & Palomaki, G. E. (2003). ACCE: A model process for evaluating data on emerging genetic tests. In M. Khoury, J. Little, & W. Burke (Eds.), Human genome epidemiology: A scientific foundation for using genetic information to improve health and prevent disease (pp. 217–233). New York: Oxford University Press.Google Scholar
- Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., et al. (2008). Feasibility of screening for lynch syndrome among patients with colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26(35), 5783–5788. doi: 10.1200/JCO.2008.17.5950.Google Scholar
- Harris, R., Sawaya, G. F., Moyer, V. A., & Calonge, N. (2011). Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. preventive services task force. Epidemiologic Reviews, 33(1), 20–35. doi: 10.1093/epirev/mxr005.PubMedGoogle Scholar
- Heald, B., Plesec, T., Liu, X., Pai, R., Patil, D., Moline, J., et al. (2013). Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 31(10), 1336–1340. doi: 10.1200/JCO.2012.45.1674.Google Scholar
- Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., et al. (1998). Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proceedings of the National Academy of Sciences, 95(12), 6870–6875.Google Scholar
- Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 10(1), 19–32. doi: 10.1097/GIM.0b013e31815f524f.Google Scholar
- Hong, S. P., Min, B. S., Kim, T. I., Cheon, J. H., Kim, N. K., Kim, H., & Kim, W. H. (2012). The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. European Journal of Cancer (Oxford, England: 1990), 48(8), 1235–1243. doi: 10.1016/j.ejca.2011.10.005.Google Scholar
- Impact of expanded newborn screening--United States, 2006. (2008). MMWR. Morbidity and Mortality Weekly Report, 57(37), 1012–1015.Google Scholar
- Informed Consent. (n.d.). Retrieved December 27, 2013, from http://www.genome.gov/10002332.
- Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomäki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118(5), 829–834.Google Scholar
- Järvinen, H. J., Renkonen-Sinisalo, L., Aktán-Collán, K., Peltomäki, P., Aaltonen, L. A., & Mecklin, J. P. (2009). Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27(28), 4793–4797. doi: 10.1200/JCO.2009.23.7784.Google Scholar
- Ladabaum, U., Wang, G., Terdiman, J., Blanco, A., Kuppermann, M., Boland, C. R., et al. (2011). Strategies to identify the lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Annals of Internal Medicine, 155(2), 69–79. doi: 10.1059/0003-4819-155-2-201107190-00002.PubMedPubMedCentralGoogle Scholar
- Landsbergen, K. M., Prins, J. B., Brunner, H. G., & Hoogerbrugge, N. (2009). Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients. Genetic Counseling (Geneva, Switzerland), 20(4), 317–325.Google Scholar
- Lerman, C., Marshall, J., Audrain, J., & Gomez-Caminero, A. (1996). Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. International Journal of Cancer. Journal International Du Cancer, 69(1), 58–61. doi: 10.1002/(SICI)1097-0215(19960220)69:1<58::AID-IJC15>3.0.CO;2-G.PubMedGoogle Scholar
- Loughrey, M. B., Waring, P. M., Tan, A., Trivett, M., Kovalenko, S., Beshay, V., et al. (2007). Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Familial Cancer, 6(3), 301–310. doi: 10.1007/s10689-007-9124-1.PubMedGoogle Scholar
- Morrison, J., Bronner, M., Leach, B. H., Downs-Kelly, E., Goldblum, J. R., & Liu, X. (2011). Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach. Scandinavian Journal of Gastroenterology, 46(11), 1340–1348. doi: 10.3109/00365521.2011.610003.PubMedGoogle Scholar
- Mvundura, M., Grosse, S. D., Hampel, H., & Palomaki, G. E. (2010). The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 12(2), 93–104. doi: 10.1097/GIM.0b013e3181cd666c.Google Scholar
- National Comprehensive Cancer Network (NCCN) Practice Guidelines Version 1.2014 Genetic/Familial High-Risk Assessment: Colorectal (2014). Retrieved April 29, 2014, from http://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf.
- Overbeek, L. I. H., Ligtenberg, M. J. L., Willems, R. W., Hermens, R. P. M. G., Blokx, W. A. M., Dubois, S. V., et al. (2008). Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. The American Journal of Surgical Pathology, 32(8), 1246–1251.PubMedGoogle Scholar
- Palomaki, G. E., McClain, M. R., Melillo, S., Hampel, H. L., & Thibodeau, S. N. (2009). EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 11(1), 42–65. doi: 10.1097/GIM.0b013e31818fa2db.Google Scholar
- Ramsey, S. D., Wilson, S., Spencer, A., Geidzinska, A., & Newcomb, P. (2003). Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives and members of the community. results of focus group interviews. Community Genetics, 6(1), 29–36. doi: 10.1159/000069543.PubMedPubMedCentralGoogle Scholar
- Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. (2009). Genetics in Medicine: Official Journal of the American College of Medical Genetics, 11(1), 35–41. doi:10.1097/GIM.0b013e31818fa2ff.Google Scholar
- Recommended Uniform Screening Panel. (n.d.). Retrieved December 27, 2013, from http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendedpanel/.
- Shia, J. (2008). Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. The Journal of Molecular Diagnostics: JMD, 10(4), 293–300. doi: 10.2353/jmoldx.2008.080031.PubMedGoogle Scholar
- Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer. (2014). Retrieved April 29, 2014, from http://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer/.
- Statewide Screening Initiative Launched By Ohio State Has Life-Saving Potential. (n.d.). Retrieved January 3, 2014, from http://cancer.osu.edu/mediaroom/releases/Pages/Statewit9de-Screening-Initiative-Launched-By-Ohio-State-Has-Life-Saving-Potential.aspx.
- Tejpar, S., Saridaki, Z., Delorenzi, M., Bosman, F., & Roth, A. D. (2011). Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzle. Journal of the National Cancer Institute, 103(11), 841–844. doi: 10.1093/jnci/djr170.PubMedGoogle Scholar
- Tranø, G., Sjursen, W., Wasmuth, H. H., Hofsli, E., & Vatten, L. J. (2010). Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study. British Journal of Cancer, 102(3), 482–488. doi: 10.1038/sj.bjc.6605509.PubMedPubMedCentralGoogle Scholar
- Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., et al. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. Journal of the National Cancer Institute, 96(4), 261–268.PubMedPubMedCentralGoogle Scholar
- Van Lier, M. G., Leenen, C. H., Wagner, A., Ramsoekh, D., Dubbink, H. J., van den Ouweland, A. M., et al. (2011). Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome. The Journal of Pathology, 226(5), 764–774. doi: 10.1002/path.3963.Google Scholar
- Watson, P., Vasen, H. F. A., Mecklin, J.-P., Bernstein, I., Aarnio, M., Järvinen, H. J., et al. (2008). The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. International Journal of Cancer. Journal International Du Cancer, 123(2), 444–449. doi: 10.1002/ijc.23508.PubMedPubMedCentralGoogle Scholar
- Wilson, J. M. G., & Jungner, G. (1968). Principles and practice of screening for disease. Public health paper number 34. Geneva: WHO.Google Scholar
- Win, A. K., Young, J. P., Lindor, N. M., Tucker, K. M., Ahnen, D. J., Young, G. P., et al. (2012). Colorectal and other cancer risks for carriers and noncarriers from families with a dna mismatch repair gene mutation: a prospective cohort study. Journal of Clinical Oncology, 30(9), 958–964. doi: 10.1200/JCO.2011.39.5590.PubMedPubMedCentralGoogle Scholar